# Corcept Therapeutics Inc: filings

CORT · Nasdaq · CIK 1088856 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cort.md) · [Financials](/companies/cort/financials.md) · [Filings](/companies/cort/filings.md) · [Insiders](/companies/cort/insiders.md)

## Reports and events: 300 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 789, 8-K 195, 144 143, SC 13G/A 75, 10-Q 53, 5 33, 424B3 22, 3 21, 10-K 18, DEF 14A 18, S-8 17, UPLOAD 16, CORRESP 14, 4/A 13, EFFECT 13, CT ORDER 12, SC 13D/A 12, S-8 POS 11, SC 13G 11, SCHEDULE 13G/A 8, S-3 7, SC TO-I/A 7, POS AM 6, 424B5 3, ARS 3, D 3, S-3/A 3, 10-K/A 2, 3/A 2, 424B2 2, 424B7 2, DEFA14A 2, SC TO-I 2, 10-Q/A 1, 144/A 1, 5/A 1, PRE 14A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 08:15 ET | [8-K](/filings/0001193125-26-398561.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-398561 |
| 2026-07-29 | 16:09 ET | [10-Q](/filings/0001628280-26-050613.md) | Quarterly report, period 2026-06-30 | 0001628280-26-050613 |
| 2026-07-29 | 16:07 ET | [8-K](/filings/0001628280-26-050607.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-050607 |
| 2026-06-17 | 16:36 ET | [8-K](/filings/0001193125-26-274258.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-274258 |
| 2026-06-03 | 08:00 ET | [8-K](/filings/0001193125-26-254622.md) | 8.01 Other events | 0001193125-26-254622 |
| 2026-05-28 | 16:04 ET | [8-K](/filings/0001628280-26-038793.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-038793 |
| 2026-04-30 | 16:14 ET | [10-Q](/filings/0001628280-26-028902.md) | Quarterly report, period 2026-03-31 | 0001628280-26-028902 |
| 2026-04-30 | 16:11 ET | [8-K](/filings/0001628280-26-028892.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-028892 |
| 2026-04-17 | 16:08 ET | [DEF 14A](/filings/0001628280-26-025735.md) | Proxy statement, period 2026-04-17 | 0001628280-26-025735 |
| 2026-03-25 | 13:31 ET | [8-K](/filings/0001193125-26-123543.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-123543 |
| 2026-02-24 | 16:13 ET | [10-K](/filings/0001628280-26-011091.md) | Annual report, period 2025-12-31 | 0001628280-26-011091 |
| 2026-02-24 | 16:10 ET | [8-K](/filings/0001628280-26-011080.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-011080 |
| 2026-02-19 | 16:38 ET | [8-K](/filings/0001193125-26-059551.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-059551 |
| 2026-01-22 | 08:10 ET | [8-K](/filings/0001193125-26-018704.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-018704 |
| 2025-12-31 | 14:51 ET | [8-K](/filings/0001193125-25-338184.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-338184 |
| 2025-11-04 | 16:12 ET | [10-Q](/filings/0001628280-25-048841.md) | Quarterly report, period 2025-09-30 | 0001628280-25-048841 |
| 2025-11-04 | 16:08 ET | [8-K](/filings/0001628280-25-048814.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001628280-25-048814 |
| 2025-10-14 | 06:02 ET | [8-K](/filings/0001193125-25-237834.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-237834 |
| 2025-10-06 | 16:36 ET | [8-K](/filings/0001193125-25-231963.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-231963 |
| 2025-09-10 | 08:09 ET | [8-K](/filings/0001193125-25-199706.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-199706 |
| 2025-07-31 | 16:10 ET | [10-Q](/filings/0001628280-25-037005.md) | Quarterly report, period 2025-06-30 | 0001628280-25-037005 |
| 2025-07-31 | 16:07 ET | [8-K](/filings/0001628280-25-036999.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001628280-25-036999 |
| 2025-07-14 | 08:05 ET | [8-K](/filings/0001193125-25-158454.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-158454 |
| 2025-06-16 | 16:47 ET | [8-K](/filings/0001628280-25-031624.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-031624 |
| 2025-05-05 | 16:09 ET | [10-Q](/filings/0001628280-25-022173.md) | Quarterly report, period 2025-03-31 | 0001628280-25-022173 |
| 2025-05-05 | 16:07 ET | [8-K](/filings/0001628280-25-022167.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-022167 |
| 2025-04-25 | 16:11 ET | [DEF 14A](/filings/0001628280-25-019942.md) | Proxy statement, period 2025-04-25 | 0001628280-25-019942 |
| 2025-03-31 | 08:05 ET | [8-K](/filings/0001193125-25-067871.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-067871 |
| 2025-03-03 | 16:14 ET | [8-K](/filings/0001193125-25-044123.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-044123 |
| 2025-02-26 | 16:18 ET | [10-K](/filings/0001628280-25-008167.md) | Annual report, period 2024-12-31 | 0001628280-25-008167 |
| 2025-02-26 | 16:06 ET | [8-K](/filings/0001628280-25-008131.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-008131 |
| 2024-12-30 | 17:20 ET | [8-K](/filings/0001193125-24-286917.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-286917 |
| 2024-10-30 | 16:12 ET | [10-Q](/filings/0001628280-24-044322.md) | Quarterly report, period 2024-09-30 | 0001628280-24-044322 |
| 2024-10-30 | 16:09 ET | [8-K](/filings/0001628280-24-044318.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-044318 |
| 2024-07-29 | 16:13 ET | [10-Q](/filings/0001628280-24-033284.md) | Quarterly report, period 2024-06-30 | 0001628280-24-033284 |
| 2024-07-29 | 16:10 ET | [8-K](/filings/0001628280-24-033281.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-033281 |
| 2024-05-23 | 16:11 ET | [8-K](/filings/0001628280-24-024936.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-024936 |
| 2024-05-01 | 16:12 ET | [10-Q](/filings/0001628280-24-019610.md) | Quarterly report, period 2024-03-31 | 0001628280-24-019610 |
| 2024-05-01 | 16:09 ET | [8-K](/filings/0001628280-24-019607.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-019607 |
| 2024-04-17 | 06:05 ET | [8-K](/filings/0001193125-24-098492.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-098492 |
| 2024-04-10 | 16:43 ET | [DEF 14A](/filings/0001628280-24-015633.md) | Proxy statement, period 2024-04-10 | 0001628280-24-015633 |
| 2024-02-15 | 16:17 ET | [10-K](/filings/0001628280-24-005055.md) | Annual report, period 2023-12-31 | 0001628280-24-005055 |
| 2024-02-15 | 16:11 ET | [8-K](/filings/0001628280-24-005048.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-005048 |
| 2024-01-08 | 08:06 ET | [8-K](/filings/0001193125-24-003933.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-003933 |
| 2024-01-02 | 08:06 ET | [8-K](/filings/0001193125-24-000247.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-000247 |
| 2023-12-11 | 16:34 ET | [8-K](/filings/0001193125-23-292621.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-292621 |
| 2023-11-01 | 16:16 ET | [10-Q](/filings/0001628280-23-035988.md) | Quarterly report, period 2023-09-30 | 0001628280-23-035988 |
| 2023-11-01 | 16:13 ET | [8-K](/filings/0001628280-23-035979.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-035979 |
| 2023-08-02 | 16:14 ET | [10-Q](/filings/0001628280-23-026768.md) | Quarterly report, period 2023-06-30 | 0001628280-23-026768 |
| 2023-08-02 | 16:09 ET | [8-K](/filings/0001628280-23-026757.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-026757 |

Page 1 of 6. [Older](/companies/cort/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:31 ET. No prices; not investment advice.